Free Trial
→ Elon's next millionaires start October 24? (From Behind the Markets) (Ad)tc pixel Free AIP Stock Alerts

Arteris (AIP) Financials

Arteris logo
$19.67 -1.49 (-7.04%)
Closing price 04:00 PM Eastern
Extended Trading
$19.28 -0.39 (-1.96%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Arteris

Annual Income Statements for Arteris

This table shows Arteris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -3.26 -23 -27 -37 -34 -35
Consolidated Net Income / (Loss)		 -3.26 -23 -27 -37 -34 -35
Net Income / (Loss) Continuing Operations		 -3.26 -23 -27 -37 -34 -35
Total Pre-Tax Income 		-2.23 -22 -28 -32 -31 -33
Total Operating Income		 -3.78 -22 -29 -35 -32 -33
Total Gross Profit		 30 34 46 49 52 64
Total Revenue		 32 38 50 54 58 71
Operating Revenue		 32 38 50 54 58 71
Total Cost of Revenue		 1.49 3.73 4.28 5.08 5.96 6.90
Operating Cost of Revenue		 - 3.73 4.28 5.08 5.96 6.90
Total Operating Expenses		 34 56 75 84 83 97
Selling, General & Admin Expense		 7.33 13 16 18 18 20
Marketing Expense		 9.75 12 17 21 21 27
Research & Development Expense		 17 31 41 45 45 50
Total Other Income / (Expense), net		 1.54 -0.47 1.34 3.35 0.46 -0.13
Interest Expense		 -1.59 - 0.09 0.21 0.24 0.19
Interest & Investment Income		 - - - - -2.70 -2.81
Other Income / (Expense), net		 -0.05 -0.47 1.43 3.56 3.40 2.87
Income Tax Expense		 1.03 1.04 -0.42 1.68 2.50 1.48
Basic Earnings per Share		 ($0.19) ($1.06) ($0.84) ($1.03) ($0.86) ($0.82)
Weighted Average Basic Shares Outstanding		 17.58M 21.97M 32.58M 35.68M 38.91M 42.29M
Diluted Earnings per Share		 ($0.19) ($1.06) ($0.84) ($1.03) ($0.86) ($0.82)
Weighted Average Diluted Shares Outstanding		 17.58M 21.97M 32.58M 35.68M 38.91M 42.29M
Weighted Average Basic & Diluted Shares Outstanding		 - 31.61M 34.79M 37.85M 40.95M 45.47M

Quarterly Income Statements for Arteris

This table shows Arteris' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -11 -9.40 -8.34 -7.69 -8.20 -8.12 -9.13 -8.99 -8.50 -7.96 -14
Consolidated Net Income / (Loss)		 -11 -9.40 -8.34 -7.69 -8.20 -8.12 -9.13 -8.99 -8.50 -7.96 -14
Net Income / (Loss) Continuing Operations		 -11 -9.40 -8.34 -7.69 -8.20 -8.12 -9.13 -8.99 -8.50 -7.96 -14
Total Pre-Tax Income 		-8.41 -8.27 -6.64 -7.20 -6.32 -7.85 -8.28 -8.13 -11 -12 -13
Total Operating Income		 -9.25 -9.13 -7.44 -7.92 -7.10 -7.71 -8.25 -8.71 -8.47 -9.30 -14
Total Gross Profit		 11 11 13 13 14 15 15 16 18 20 21
Total Revenue		 13 13 15 15 15 17 17 17 20 23 24
Operating Revenue		 13 13 15 15 15 17 17 17 20 23 24
Total Cost of Revenue		 1.45 1.47 1.46 1.46 1.58 1.53 1.74 1.77 1.86 3.25 3.61
Operating Cost of Revenue		 1.45 1.47 1.46 1.46 1.58 1.53 1.74 1.77 1.86 3.25 3.61
Total Operating Expenses		 20 21 21 21 21 23 23 24 27 29 34
Selling, General & Admin Expense		 4.61 4.32 4.83 4.29 4.12 4.32 4.50 4.86 6.45 5.42 6.07
Marketing Expense		 5.03 5.46 5.01 4.96 5.37 6.53 6.34 6.85 7.07 8.53 9.39
Research & Development Expense		 11 11 11 12 12 12 12 13 13 14 17
Restructuring Charge		 - - - - - 0.00 0.00 - - 0.58 2.22
Total Other Income / (Expense), net		 0.84 0.86 0.80 0.72 0.78 -0.15 -0.04 0.59 -2.14 -2.36 0.54
Interest Expense		 0.08 0.08 0.07 0.06 0.05 0.05 0.04 0.05 0.05 0.04 0.03
Interest & Investment Income		 - - - - - -0.82 -0.78 - - -2.99 0.00
Other Income / (Expense), net		 0.92 0.94 0.87 0.78 0.82 0.72 0.79 0.64 0.73 0.67 0.57
Income Tax Expense		 1.22 0.37 0.98 -0.09 1.25 0.27 0.85 0.38 -0.02 -3.70 0.70
Basic Earnings per Share		 ($0.28) ($0.25) ($0.22) ($0.20) ($0.19) ($0.20) ($0.22) ($0.21) ($0.19) ($0.17) ($0.30)
Weighted Average Basic Shares Outstanding		 35.68M 37.71M 38.48M 39.30M 38.91M 40.85M 41.82M 42.74M 42.29M 45.54M 47.28M
Diluted Earnings per Share		 ($0.28) ($0.25) ($0.22) ($0.20) ($0.19) ($0.20) ($0.22) ($0.21) ($0.19) ($0.17) ($0.30)
Weighted Average Diluted Shares Outstanding		 35.68M 37.71M 38.48M 39.30M 38.91M 40.85M 41.82M 42.74M 42.29M 45.54M 47.28M
Weighted Average Basic & Diluted Shares Outstanding		 37.85M 38.48M 39.26M 40.18M 40.95M 41.98M 42.65M 43.68M 45.47M 46.17M 49.15M

Annual Cash Flow Statements for Arteris

This table details how cash moves in and out of Arteris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -2.19 74 -48 -23 -0.01 20
Net Cash From Operating Activities		 2.16 -0.81 -6.77 -16 -0.72 6.73
Net Cash From Continuing Operating Activities		 2.16 -0.81 -6.77 -16 -0.72 6.73
Net Income / (Loss) Continuing Operations		 -3.26 -23 -27 -37 -34 -35
Consolidated Net Income / (Loss)		 -3.26 -23 -27 -37 -34 -35
Depreciation Expense		 0.94 1.49 2.10 3.07 3.36 3.38
Amortization Expense		 - 0.00 -0.57 -2.07 -1.88 -1.55
Non-Cash Adjustments To Reconcile Net Income		 -0.57 5.57 12 18 19 22
Changes in Operating Assets and Liabilities, net		 5.06 16 7.13 1.95 13 18
Net Cash From Investing Activities		 -5.15 -1.36 -37 -4.69 0.97 12
Net Cash From Continuing Investing Activities		 -5.15 -1.36 -37 -4.69 0.97 12
Purchase of Property, Plant & Equipment		 -0.65 -0.81 -1.05 -1.50 -0.32 -1.39
Purchase of Investments		 - 0.00 -35 -48 -37 -30
Sale and/or Maturity of Investments		 - 0.00 0.24 45 38 43
Net Cash From Financing Activities		 0.79 76 -4.15 -2.92 -0.26 1.42
Net Cash From Continuing Financing Activities		 0.79 76 -4.15 -2.92 -0.26 1.42
Repayment of Debt		 -0.61 -1.12 0.00 0.08 0.06 0.07
Issuance of Common Equity		 0.00 80 - 0.00 0.54 0.98
Other Financing Activities, net		 1.40 0.60 -3.90 -3.00 -0.86 0.36
Cash Income Taxes Paid		 1.53 0.49 0.79 1.29 1.55 2.82

Quarterly Cash Flow Statements for Arteris

This table details how cash moves in and out of Arteris' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -4.93 12 -3.99 -4.30 -4.15 2.69 -0.27 1.38 16 -22 82
Net Cash From Operating Activities		 -2.98 0.48 0.31 1.12 -2.63 2.86 -2.49 3.19 3.17 -7.06 9.21
Net Cash From Continuing Operating Activities		 -2.98 0.48 0.31 1.12 -2.63 2.86 -2.49 3.19 3.17 -7.06 9.21
Net Income / (Loss) Continuing Operations		 -11 -9.40 -8.34 -7.69 -8.20 -8.12 -9.13 -8.99 -8.50 -7.96 -14
Consolidated Net Income / (Loss)		 -11 -9.40 -8.34 -7.69 -8.20 -8.12 -9.13 -8.99 -8.50 -7.96 -14
Depreciation Expense		 0.83 0.83 0.80 0.84 0.89 0.84 0.85 0.84 0.84 1.35 1.52
Amortization Expense		 -0.49 -0.48 -0.46 -0.48 -0.47 -0.42 -0.39 -0.38 -0.36 -0.34 -0.32
Non-Cash Adjustments To Reconcile Net Income		 4.73 4.45 4.48 5.07 4.80 5.31 5.47 5.45 5.56 8.41 6.38
Changes in Operating Assets and Liabilities, net		 2.50 5.08 3.84 3.37 0.36 5.25 0.72 6.27 5.63 -8.53 16
Net Cash From Investing Activities		 -1.37 12 -4.36 -4.65 -1.93 -0.12 0.71 -1.63 13 -16 -0.37
Net Cash From Continuing Investing Activities		 -1.37 12 -4.36 -4.65 -1.93 -0.12 0.71 -1.63 13 -16 -0.37
Purchase of Property, Plant & Equipment		 -0.43 -0.20 -0.05 -0.03 -0.05 -0.18 -0.36 -0.72 -0.13 -0.30 -0.60
Purchase of Investments		 -12 -3.42 -9.56 -13 -11 -8.74 -8.42 -8.15 -4.22 -10 -5.98
Sale and/or Maturity of Investments		 12 16 5.25 8.40 9.30 8.80 9.48 7.23 17 5.78 6.20
Net Cash From Financing Activities		 -0.58 0.04 0.06 -0.78 0.41 -0.05 1.51 -0.18 0.14 0.88 73
Net Cash From Continuing Financing Activities		 -0.58 0.04 0.06 -0.78 0.41 -0.05 1.51 -0.18 0.14 0.88 73
Repayment of Debt		 - 0.00 - 0.06 - 0.03 - 0.07 -0.03 0.03 0.07
Issuance of Common Equity		 - - - - - 0.00 - - 0.45 0.84 72
Other Financing Activities, net		 -0.58 0.04 0.06 -0.83 -0.12 -0.08 0.97 -0.25 -0.28 0.01 0.34

Annual Balance Sheets for Arteris

This table presents Arteris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 43 120 116 103 106 115
Total Current Assets		 29 107 81 58 69 82
Cash & Equivalents		 12 86 37 14 14 34
Short-Term Investments		 - 0.00 31 27 30 21
Accounts Receivable		 14 14 7.14 12 21 19
Prepaid Expenses		 2.86 6.95 5.82 5.25 4.63 8.61
Plant, Property, & Equipment, net		 2.37 2.44 3.62 5.75 4.02 3.87
Total Noncurrent Assets		 11 11 31 39 33 29
Long-Term Investments		 - 0.00 16 20 14 7.94
Goodwill		 2.68 2.68 4.22 4.18 4.18 4.18
Intangible Assets		 3.41 2.96 4.58 3.86 3.02 2.17
Other Noncurrent Operating Assets		 5.33 5.72 5.67 10 12 14
Total Liabilities & Shareholders' Equity		 43 120 116 103 106 115
Total Liabilities		 49 68 78 88 107 130
Total Current Liabilities		 28 42 44 46 59 73
Accounts Payable		 1.12 1.72 0.57 0.18 0.54 0.34
Accrued Expenses		 7.25 11 12 12 16 19
Current Deferred Revenue		 18 28 29 32 40 51
Other Current Liabilities		 1.41 1.79 2.16 2.85 2.40 2.40
Total Noncurrent Liabilities		 21 25 34 41 48 56
Noncurrent Deferred Revenue		 15 21 32 34 43 44
Other Noncurrent Operating Liabilities		 5.79 4.27 2.48 7.31 5.23 12
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -12 53 38 15 -1.19 -15
Total Preferred & Common Equity		 -12 53 38 15 -1.19 -15
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 -12 53 38 15 -1.19 -15
Common Stock		 3.63 92 104 118 136 157
Retained Earnings		 -16 -39 -66 -103 -137 -172
Accumulated Other Comprehensive Income / (Loss)		 -0.03 -0.08 0.10 0.12 0.14 0.18

Quarterly Balance Sheets for Arteris

This table presents Arteris' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 107 102 101 96 98 98 107 108 140 225
Total Current Assets		 70 62 62 59 63 57 62 61 62 146
Cash & Equivalents		 26 19 26 22 18 16 16 17 12 93
Short-Term Investments		 29 28 19 24 31 26 22 22 26 29
Accounts Receivable		 9.58 10 12 8.95 8.72 10 19 16 15 15
Prepaid Expenses		 5.86 5.25 4.72 4.20 5.40 4.82 4.83 5.57 8.74 9.06
Plant, Property, & Equipment, net		 5.17 5.43 5.24 4.67 4.06 3.43 4.29 4.46 3.59 5.97
Total Noncurrent Assets		 31 35 34 33 31 37 41 42 75 72
Long-Term Investments		 16 20 16 15 12 18 20 21 3.78 1.20
Goodwill		 4.18 4.18 4.18 4.18 4.18 4.18 4.18 4.18 35 35
Intangible Assets		 4.19 4.05 3.66 3.47 3.25 2.80 2.58 2.36 20 19
Other Noncurrent Operating Assets		 6.71 6.84 10 10 11 13 14 15 16 17
Total Liabilities & Shareholders' Equity		 107 102 101 96 98 98 107 108 140 225
Total Liabilities		 80 80 92 91 96 103 114 119 137 157
Total Current Liabilities		 44 45 50 52 54 57 63 67 85 93
Accounts Payable		 0.21 0.45 0.75 0.34 0.14 0.23 0.86 0.52 0.56 0.56
Accrued Expenses		 11 12 13 12 13 14 15 17 27 30
Current Deferred Revenue		 30 30 34 37 39 40 43 46 55 60
Other Current Liabilities		 2.29 2.19 2.85 2.74 2.12 2.43 3.06 2.80 2.20 2.77
Total Noncurrent Liabilities		 36 36 42 39 41 47 52 52 53 64
Noncurrent Deferred Revenue		 32 23 35 33 27 41 46 46 40 49
Other Noncurrent Operating Liabilities		 3.80 13 6.91 6.64 15 5.71 6.18 6.04 13 14
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 27 22 9.55 5.28 2.21 -4.82 -7.53 -11 2.59 68
Total Preferred & Common Equity		 27 22 9.55 5.28 2.21 -4.82 -7.53 -11 2.59 68
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 27 22 9.55 5.28 2.21 -4.82 -7.53 -11 2.59 68
Common Stock		 111 115 122 126 131 140 146 151 182 261
Retained Earnings		 -85 -93 -113 -121 -129 -145 -154 -163 -180 -194
Accumulated Other Comprehensive Income / (Loss)		 0.03 0.05 0.05 0.04 0.17 0.13 0.22 0.26 0.12 0.11

Annual Metrics And Ratios for Arteris

This table displays calculated financial ratios and metrics derived from Arteris' official financial filings.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 19.02% 33.05% 6.53% 7.56% 22.27%
EBITDA Growth		 0.00% -617.39% -24.84% -18.10% 12.67% -6.46%
EBIT Growth		 0.00% -481.11% -23.35% -15.14% 10.73% -7.34%
NOPAT Growth		 0.00% -476.25% -32.58% -21.78% 10.09% -4.88%
Net Income Growth		 0.00% -617.30% -17.12% -34.62% 8.76% -3.29%
EPS Growth		 0.00% -457.89% 20.75% -22.62% 16.50% 4.65%
Operating Cash Flow Growth		 0.00% -137.63% -731.33% -132.44% 95.42% 1,035.14%
Free Cash Flow Firm Growth		 0.00% 0.00% -3,151.95% -307.23% 63.63% 41.39%
Invested Capital Growth		 0.00% -88.30% -42.58% 1.21% -27.95% -30.05%
Revenue Q/Q Growth		 0.00% 0.00% -0.46% 2.48% 5.45% 7.05%
EBITDA Q/Q Growth		 0.00% 0.00% -4.49% -0.04% 7.40% -5.14%
EBIT Q/Q Growth		 0.00% 0.00% -2.94% -0.93% 6.79% -5.06%
NOPAT Q/Q Growth		 0.00% 0.00% -6.57% -0.54% 6.36% -4.30%
Net Income Q/Q Growth		 0.00% 0.00% 2.06% -9.92% 6.50% -0.87%
EPS Q/Q Growth		 0.00% 0.00% 5.62% -7.29% 9.47% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 39.30% -112.53% -19.69% 32.58% 622.42%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 6.25% -2.69% 44.01%
Invested Capital Q/Q Growth		 0.00% 0.00% -1.15% -5.32% -1.02% -8.09%
Profitability Metrics		 - - - - - -
Gross Margin		 95.31% 90.15% 91.50% 90.54% 89.67% 90.23%
EBITDA Margin		 -9.09% -54.79% -51.41% -57.00% -46.27% -40.29%
Operating Margin		 -11.87% -57.48% -57.28% -65.48% -54.74% -46.95%
EBIT Margin		 -12.03% -58.73% -54.45% -58.85% -48.85% -42.88%
Profit (Net Income) Margin		 -10.25% -61.76% -54.36% -68.70% -58.27% -49.23%
Tax Burden Percent		 145.93% 105.15% 99.52% 115.96% 118.28% 104.43%
Interest Burden Percent		 58.37% 100.00% 100.32% 100.67% 100.87% 109.93%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 51.78% -100.34% -60.56% -140.09% -483.48% 439.27%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -8.96% -27.26% -23.25% -28.93% -26.99% -27.37%
Return on Assets (ROA)		 -7.63% -28.66% -23.21% -33.78% -32.20% -31.42%
Return on Common Equity (ROCE)		 98.75% -88.05% -60.56% -140.09% -483.48% 439.27%
Return on Equity Simple (ROE_SIMPLE)		 27.15% -44.20% -72.96% -244.12% 2,831.48% 0.00%
Net Operating Profit after Tax (NOPAT)		 -2.64 -15 -20 -25 -22 -23
NOPAT Margin		 -8.31% -40.24% -40.10% -45.84% -38.32% -32.87%
Net Nonoperating Expense Percent (NNEP)		 -5.51% -16.80% -8.44% -16.81% -19.26% -19.14%
Return On Investment Capital (ROIC_SIMPLE)		 - - - -162.88% 1,861.72% 158.53%
Cost of Revenue to Revenue		 4.69% 9.85% 8.50% 9.46% 10.33% 9.77%
SG&A Expenses to Revenue		 23.04% 35.28% 32.49% 33.44% 30.41% 28.52%
R&D to Revenue		 53.50% 81.38% 81.72% 84.09% 77.97% 70.71%
Operating Expenses to Revenue		 107.19% 147.63% 148.78% 156.02% 144.41% 137.18%
Earnings before Interest and Taxes (EBIT)		 -3.83 -22 -27 -32 -28 -30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -2.89 -21 -26 -31 -27 -28
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 12.47 3.83 14.37 0.00 0.00
Price to Tangible Book Value (P/TBV)		 0.00 13.96 5.00 30.72 0.00 0.00
Price to Revenue (P/Rev)		 2.20 17.43 2.85 4.04 7.09 9.59
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.03 15.16 1.18 2.90 6.09 8.71
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 29.83 0.00 0.00 0.00 0.00 91.28
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 2,834.40 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 -0.09 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 1.78 -2.08 -1.88 -2.77 -8.60 7.63
Leverage Ratio		 -6.79 3.50 2.61 4.15 15.02 -13.98
Compound Leverage Factor		 -3.96 3.50 2.62 4.18 15.15 -15.37
Debt to Total Capital		 -9.71% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 -9.71% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 -99.53% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 209.24% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 -0.19 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 3.87 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 -0.21 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 4.23 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.81 5.75 0.34 -0.27 0.26 0.89
Noncontrolling Interest Sharing Ratio		 -90.72% 12.26% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - -
Current Ratio		 1.03 2.51 1.86 1.26 1.17 1.13
Quick Ratio		 0.92 2.35 1.72 1.15 1.09 1.01
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.20 -6.18 -25 -9.15 -5.36
Operating Cash Flow to CapEx		 330.73% -100.74% -643.86% -1,046.51% -222.22% 485.09%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 -69.44 -119.28 -37.52 -27.80
Operating Cash Flow to Interest Expense		 0.00 0.00 -76.03 -74.55 -2.95 34.89
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 -87.84 -81.67 -4.28 27.69
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.74 0.46 0.43 0.49 0.55 0.64
Accounts Receivable Turnover		 2.22 2.68 4.79 5.61 3.54 3.55
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 13.45 15.77 16.64 11.46 11.82 17.89
Accounts Payable Turnover		 1.34 2.63 3.73 13.45 16.52 15.69
Days Sales Outstanding (DSO)		 164.65 136.03 76.13 65.11 103.10 102.89
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 273.20 138.82 97.79 27.14 22.10 23.27
Cash Conversion Cycle (CCC)		 -108.55 -2.79 -21.66 37.97 81.00 79.62
Capital & Investment Metrics		 - - - - - -
Invested Capital		 -17 -33 -47 -46 -59 -77
Invested Capital Turnover		 -1.82 -1.50 -1.26 -1.15 -1.09 -1.03
Increase / (Decrease) in Invested Capital		 0.00 -15 -14 0.57 -13 -18
Enterprise Value (EV)		 65 574 59 156 351 615
Market Capitalization		 70 660 144 217 409 677
Book Value per Share		 ($0.68) $1.69 $1.12 $0.41 ($0.03) ($0.34)
Tangible Book Value per Share		 ($1.03) $1.51 $0.86 $0.19 ($0.21) ($0.48)
Total Capital		 -5.74 53 38 15 -1.19 -15
Total Debt		 0.56 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -11 -86 -84 -61 -58 -63
Capital Expenditures (CapEx)		 0.65 0.81 1.05 1.50 0.32 1.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -10 -22 -31 -29 -34 -45
Debt-free Net Working Capital (DFNWC)		 1.28 64 37 12 9.80 9.19
Net Working Capital (NWC)		 0.73 64 37 12 9.80 9.19
Net Nonoperating Expense (NNE)		 0.62 8.15 7.19 12 12 12
Net Nonoperating Obligations (NNO)		 -11 -86 -84 -61 -58 -63
Total Depreciation and Amortization (D&A)		 0.94 1.49 1.53 1.00 1.49 1.83
Debt-free, Cash-free Net Working Capital to Revenue		 -32.88% -57.23% -60.96% -54.31% -58.97% -64.34%
Debt-free Net Working Capital to Revenue		 4.03% 169.44% 74.32% 22.41% 16.98% 13.02%
Net Working Capital to Revenue		 2.28% 169.44% 74.32% 22.41% 16.98% 13.02%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($1.06) ($0.84) ($1.03) ($0.86) ($0.82)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 21.97M 32.58M 35.68M 38.91M 42.29M
Adjusted Diluted Earnings per Share		 $0.00 ($1.06) ($0.84) ($1.03) ($0.86) ($0.82)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 21.97M 32.58M 35.68M 38.91M 42.29M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 31.61M 34.79M 37.85M 40.95M 45.47M
Normalized Net Operating Profit after Tax (NOPAT)		 -2.64 -15 -20 -25 -22 -23
Normalized NOPAT Margin		 -8.31% -40.24% -40.10% -45.84% -38.32% -32.87%
Pre Tax Income Margin		 -7.02% -58.73% -54.63% -59.25% -49.27% -47.14%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 -308.21 -149.69 -115.56 -156.81
NOPAT to Interest Expense		 0.00 0.00 -226.96 -116.58 -90.64 -120.19
EBIT Less CapEx to Interest Expense		 0.00 0.00 -320.02 -156.81 -116.89 -164.01
NOPAT Less CapEx to Interest Expense		 0.00 0.00 -238.77 -123.71 -91.97 -127.38
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% -15.06% -0.93% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Arteris

This table displays calculated financial ratios and metrics derived from Arteris' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 36,854,383.00 36,854,383.00 38,479,122.00 39,257,166.00 - 40,948,190.00 41,977,728.00 42,649,917.00 - 45,467,261.00 46,171,982.00
DEI Adjusted Shares Outstanding		 36,854,383.00 36,854,383.00 38,479,122.00 39,257,166.00 - 40,948,190.00 41,977,728.00 42,649,917.00 - 45,467,261.00 46,171,982.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.29 -0.26 -0.22 -0.20 - -0.20 -0.22 -0.21 - -0.18 -0.30
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 11.61% -1.57% -1.08% 10.84% 23.87% 27.69% 13.22% 18.32% 30.01% 38.74% 46.25%
EBITDA Growth		 -0.14% -0.54% 19.08% 4.42% 26.70% 16.26% -12.32% -12.43% -23.72% -16.10% -73.32%
EBIT Growth		 -3.62% -4.45% 16.21% 5.44% 24.65% 14.74% -13.47% -13.07% -23.21% -23.46% -78.75%
NOPAT Growth		 -2.09% -4.31% 14.30% 6.32% 23.21% 15.61% -10.85% -10.04% -19.22% -20.65% -68.62%
Net Income Growth		 -46.10% -4.36% 8.96% 5.72% 22.17% 13.63% -9.42% -16.96% -3.66% 1.99% -54.05%
EPS Growth		 -33.33% 3.85% 15.38% 13.04% 32.14% 20.00% 0.00% -5.00% 0.00% 15.00% -36.36%
Operating Cash Flow Growth		 -661.89% 105.69% 120.00% 140.02% 11.68% 499.58% -899.04% 183.88% 220.49% -346.92% 470.62%
Free Cash Flow Firm Growth		 -191.73% 28.13% 164.39% 210.46% 213.48% 211.60% -32.14% -28.43% 48.96% -506.91% -569.86%
Invested Capital Growth		 1.21% -20.91% -25.78% -33.40% -27.95% -25.75% -17.94% -21.55% -30.05% 39.46% 15.26%
Revenue Q/Q Growth		 -5.80% 3.54% 12.57% 0.95% 5.27% 6.73% -0.18% 5.49% 15.68% 13.90% 5.22%
EBITDA Q/Q Growth		 -12.80% 1.94% 20.46% -8.64% 13.51% -12.03% -6.69% -8.75% 4.82% -5.13% -59.26%
EBIT Q/Q Growth		 -10.28% 1.61% 19.79% -8.64% 12.12% -11.34% -6.75% -8.26% 4.25% -11.57% -54.55%
NOPAT Q/Q Growth		 -9.42% 1.24% 18.54% -6.42% 10.32% -8.53% -7.01% -5.65% 2.83% -9.84% -49.55%
Net Income Q/Q Growth		 -29.29% 10.80% 11.26% 7.87% -6.73% 1.01% -12.42% 1.52% 5.42% 6.41% -76.72%
EPS Q/Q Growth		 -21.74% 10.71% 12.00% 9.09% 5.00% -5.26% -10.00% 4.55% 9.52% 10.53% -76.47%
Operating Cash Flow Q/Q Growth		 -6.17% 116.01% -34.80% 261.09% -334.28% 208.70% -186.89% 228.29% -0.56% -322.78% 230.42%
Free Cash Flow Firm Q/Q Growth		 15.10% 135.97% 144.45% 47.97% -12.78% -1.23% -46.76% 56.06% 81.51% -369.81% 38.52%
Invested Capital Q/Q Growth		 -5.32% -11.30% -7.77% -5.60% -1.02% -9.38% -1.08% -8.83% -8.09% 49.08% -41.48%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 88.42% 88.66% 90.00% 90.07% 89.83% 90.77% 89.44% 89.86% 90.76% 85.83% 85.05%
EBITDA Margin		 -63.94% -60.55% -42.79% -46.05% -37.83% -39.71% -42.44% -43.76% -36.00% -33.23% -50.30%
Operating Margin		 -73.97% -70.55% -51.05% -53.82% -45.85% -46.62% -49.98% -50.06% -42.05% -40.55% -57.63%
EBIT Margin		 -66.63% -63.32% -45.12% -48.56% -40.53% -42.28% -45.22% -46.40% -38.41% -37.63% -55.27%
Profit (Net Income) Margin		 -84.30% -72.63% -57.25% -52.25% -52.97% -49.12% -55.33% -51.65% -42.23% -34.70% -58.28%
Tax Burden Percent		 125.38% 113.65% 125.59% 106.78% 129.75% 115.39% 121.67% 110.63% 80.21% 68.28% 105.21%
Interest Burden Percent		 100.90% 100.93% 101.03% 100.77% 100.72% 100.69% 100.56% 100.61% 137.07% 135.08% 100.22%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Equity (ROE)		 -140.09% -180.38% -226.38% -296.85% -483.48% -1,369.57% 2,940.73% 745.58% 439.27% 3,101.70% -131.41%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 -32.76% -32.45% -23.67% -26.59% -22.40% -25.96% -28.14% -29.78% -24.52% -24.32% -28.21%
Return on Assets (ROA)		 -41.45% -37.22% -30.03% -28.62% -29.27% -30.17% -34.43% -33.15% -26.95% -22.43% -29.74%
Return on Common Equity (ROCE)		 -140.09% -180.38% -226.38% -296.85% -483.48% -1,369.57% 2,940.73% 745.58% 439.27% 3,101.70% -131.41%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -390.34% 0.00% 0.00% 0.00% 671.15% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -6.47 -6.39 -5.21 -5.54 -4.97 -5.40 -5.77 -6.10 -5.93 -6.51 -9.74
NOPAT Margin		 -51.78% -49.38% -35.74% -37.68% -32.10% -32.64% -34.99% -35.04% -29.43% -28.38% -40.34%
Net Nonoperating Expense Percent (NNEP)		 -5.57% -4.44% -4.75% -3.38% -5.40% -4.50% -5.64% -4.78% -4.27% -2.84% -4.78%
Return On Investment Capital (ROIC_SIMPLE)		 -42.87% -66.98% -98.74% -250.94% 418.47% 111.92% 76.68% 53.28% 40.51% -251.25% -14.39%
Cost of Revenue to Revenue		 11.58% 11.34% 10.00% 9.93% 10.17% 9.23% 10.56% 10.14% 9.24% 14.17% 14.95%
SG&A Expenses to Revenue		 36.89% 33.38% 33.13% 29.13% 26.59% 26.15% 27.28% 27.91% 32.02% 23.61% 25.16%
R&D to Revenue		 85.28% 83.69% 73.53% 81.04% 74.45% 71.75% 73.75% 72.66% 65.69% 63.03% 69.45%
Operating Expenses to Revenue		 162.39% 159.21% 141.05% 143.89% 135.68% 137.39% 139.43% 139.91% 132.81% 126.38% 142.68%
Earnings before Interest and Taxes (EBIT)		 -8.33 -8.20 -6.58 -7.14 -6.28 -6.99 -7.46 -8.08 -7.74 -8.63 -13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.00 -7.84 -6.24 -6.78 -5.86 -6.57 -7.00 -7.62 -7.25 -7.62 -12
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 14.37 28.26 54.78 137.20 0.00 0.00 0.00 0.00 0.00 288.49 33.15
Price to Tangible Book Value (P/TBV)		 30.72 158.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 164.87
Price to Revenue (P/Rev)		 4.04 5.05 5.42 5.54 7.09 4.62 6.33 6.53 9.59 9.71 26.51
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Revenue (EV/Rev)		 2.90 3.90 4.28 4.42 6.09 3.64 5.41 5.62 8.71 9.17 25.06
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 134.02 0.00 397.88 91.28 0.00 249.26
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -2.77 -3.28 -4.10 -5.24 -8.60 -25.66 52.78 13.08 7.63 45.72 -3.01
Leverage Ratio		 4.15 5.05 6.31 8.25 15.02 42.26 -90.17 -22.24 -13.98 -106.81 5.51
Compound Leverage Factor		 4.18 5.10 6.38 8.31 15.12 42.55 -90.68 -22.37 -19.16 -144.28 5.53
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 0.47 0.61 0.56 0.48 0.94 -0.02 0.43 0.35 1.53 1.62 7.83
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.26 1.24 1.14 1.16 1.17 1.02 0.98 0.91 1.13 0.73 1.57
Quick Ratio		 1.15 1.15 1.06 1.06 1.09 0.93 0.91 0.83 1.01 0.62 1.47
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -7.04 2.53 6.19 9.16 7.99 7.89 4.20 6.56 12 -32 -20
Operating Cash Flow to CapEx		 -696.03% 243.37% 661.70% 3,622.58% -5,262.00% 1,562.84% -700.00% 445.25% 2,365.67% -2,393.90% 1,547.90%
Free Cash Flow to Firm to Interest Expense		 -93.90 33.33 91.06 166.59 177.59 164.45 100.06 133.84 220.45 -845.24 -658.19
Operating Cash Flow to Interest Expense		 -39.72 6.28 4.57 20.42 -58.47 59.58 -59.17 65.06 58.70 -185.84 307.00
Operating Cash Flow Less CapEx to Interest Expense		 -45.43 3.70 3.88 19.85 -59.58 55.77 -67.62 50.45 56.22 -193.61 287.17
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.49 0.51 0.52 0.55 0.55 0.61 0.62 0.64 0.64 0.65 0.51
Accounts Receivable Turnover		 5.61 4.86 5.75 5.74 3.54 5.44 4.57 5.23 3.55 6.17 4.98
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 11.46 12.49 10.84 11.54 11.82 14.13 14.12 15.48 17.89 21.91 16.50
Accounts Payable Turnover		 13.45 5.51 20.56 19.91 16.52 12.27 10.54 20.09 15.69 21.82 14.83
Days Sales Outstanding (DSO)		 65.11 75.16 63.44 63.63 103.10 67.07 79.94 69.74 102.89 59.18 73.28
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 27.14 66.29 17.75 18.33 22.10 29.74 34.62 18.17 23.27 16.73 24.61
Cash Conversion Cycle (CCC)		 37.97 8.87 45.69 45.30 81.00 37.33 45.32 51.57 79.62 42.45 48.66
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -46 -52 -56 -59 -59 -65 -66 -71 -77 -39 -56
Invested Capital Turnover		 -1.15 -1.13 -1.07 -1.07 -1.09 -1.05 -1.04 -1.01 -1.03 -1.48 -1.40
Increase / (Decrease) in Invested Capital		 0.57 -8.93 -11 -15 -13 -13 -9.98 -13 -18 26 10
Enterprise Value (EV)		 156 209 228 242 351 223 342 371 615 706 2,120
Market Capitalization		 217 270 289 303 409 283 400 431 677 747 2,243
Book Value per Share		 $0.41 $0.25 $0.14 $0.06 ($0.03) ($0.12) ($0.18) ($0.27) ($0.34) $0.06 $1.47
Tangible Book Value per Share		 $0.19 $0.05 ($0.06) ($0.13) ($0.21) ($0.29) ($0.34) ($0.42) ($0.48) ($1.15) $0.29
Total Capital		 15 9.55 5.28 2.21 -1.19 -4.82 -7.53 -11 -15 2.59 68
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -61 -61 -61 -61 -58 -60 -58 -60 -63 -42 -123
Capital Expenditures (CapEx)		 0.43 0.20 0.05 0.03 0.05 0.18 0.36 0.72 0.13 0.30 0.60
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -29 -33 -39 -40 -34 -41 -39 -45 -45 -61 -69
Debt-free Net Working Capital (DFNWC)		 12 12 7.18 8.56 9.80 0.87 -1.02 -5.74 9.19 -23 53
Net Working Capital (NWC)		 12 12 7.18 8.56 9.80 0.87 -1.02 -5.74 9.19 -23 53
Net Nonoperating Expense (NNE)		 4.07 3.01 3.14 2.14 3.23 2.73 3.36 2.89 2.58 1.45 4.33
Net Nonoperating Obligations (NNO)		 -61 -61 -61 -61 -58 -60 -58 -60 -63 -42 -123
Total Depreciation and Amortization (D&A)		 0.34 0.36 0.34 0.37 0.42 0.43 0.46 0.46 0.49 1.01 1.20
Debt-free, Cash-free Net Working Capital to Revenue		 -54.31% -61.42% -72.38% -73.27% -58.97% -67.61% -61.63% -67.84% -64.34% -79.35% -81.63%
Debt-free Net Working Capital to Revenue		 22.41% 22.41% 13.47% 15.64% 16.98% 1.41% -1.61% -8.71% 13.02% -29.86% 62.63%
Net Working Capital to Revenue		 22.41% 22.41% 13.47% 15.64% 16.98% 1.41% -1.61% -8.71% 13.02% -29.86% 62.63%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.28) ($0.25) ($0.22) ($0.20) ($0.19) ($0.20) ($0.22) ($0.21) ($0.19) ($0.17) ($0.30)
Adjusted Weighted Average Basic Shares Outstanding		 35.68M 37.71M 38.48M 39.30M 38.91M 40.85M 41.82M 42.74M 42.29M 45.54M 47.28M
Adjusted Diluted Earnings per Share		 ($0.28) ($0.25) ($0.22) ($0.20) ($0.19) ($0.20) ($0.22) ($0.21) ($0.19) ($0.17) ($0.30)
Adjusted Weighted Average Diluted Shares Outstanding		 35.68M 37.71M 38.48M 39.30M 38.91M 40.85M 41.82M 42.74M 42.29M 45.54M 47.28M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 37.85M 38.48M 39.26M 40.18M 40.95M 41.98M 42.65M 43.68M 45.47M 46.17M 49.15M
Normalized Net Operating Profit after Tax (NOPAT)		 -6.47 -6.39 -5.21 -5.54 -4.97 -5.40 -5.77 -6.10 -5.93 -6.10 -8.19
Normalized NOPAT Margin		 -51.78% -49.38% -35.74% -37.68% -32.10% -32.64% -34.99% -35.04% -29.43% -26.60% -33.92%
Pre Tax Income Margin		 -67.23% -63.91% -45.58% -48.93% -40.82% -42.57% -45.47% -46.69% -52.65% -50.82% -55.39%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -111.09 -107.87 -96.71 -129.89 -139.51 -145.63 -177.67 -164.86 -143.24 -227.11 -444.60
NOPAT to Interest Expense		 -86.32 -84.13 -76.60 -100.79 -110.48 -112.41 -137.47 -124.49 -109.76 -171.32 -324.52
EBIT Less CapEx to Interest Expense		 -116.80 -110.45 -97.40 -130.45 -140.62 -149.44 -186.12 -179.47 -145.72 -234.87 -464.43
NOPAT Less CapEx to Interest Expense		 -92.03 -86.71 -77.29 -101.35 -111.59 -116.22 -145.92 -139.10 -112.24 -179.08 -344.35
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Arteris’ recent results show strong revenue growth and a much larger liquidity position, but the company remains deeply unprofitable and increasingly reliant on equity financing. Q2 2026 revenue rose to $24.1 million, up 46.3% from $16.5 million in Q2 2025 and approximately 92% from Q2 2024. Revenue has generally trended higher across the periods provided, although growth has not yet translated into operating profitability.

Gross margins remain high. Q2 2026 gross profit was $20.5 million, representing an 85.1% gross margin, compared with 89.4% in Q2 2025 and 90.0% in Q2 2024. The slight margin compression reflects cost of revenue growing faster than sales in the latest quarter.

Operating expenses continue to consume substantially more than gross profit. Q2 2026 operating expenses reached $34.4 million, including $16.8 million of research and development, $9.4 million of marketing, $6.1 million of selling, general and administrative costs, and a $2.2 million restructuring charge. Consequently, operating loss widened to $13.9 million from $8.2 million in Q2 2025.

Cash generation was mixed. Arteris produced $9.2 million of operating cash flow in Q2 2026 after using $7.1 million in Q1, but the latest result benefited significantly from a $15.7 million favorable change in operating assets and liabilities and $6.4 million of non-cash adjustments. The company also raised $72.3 million through common equity issuance, which was the primary driver of the $81.6 million quarterly increase in cash.

The balance sheet improved materially by June 30, 2026. Cash and equivalents increased to $93.3 million from $11.7 million at the end of Q1, while short-term investments rose to $28.8 million. Total equity improved to $67.7 million from $2.6 million in the prior quarter and negative equity in 2025. However, total liabilities remained high at $157.0 million, including $109.0 million of deferred revenue and $30.4 million of accrued expenses.

  • Revenue momentum accelerated: Q2 2026 revenue increased 46.3% year over year, following growth of approximately 39% in Q2 2025 versus Q2 2024.
  • High gross-margin business model: Q2 2026 gross margin remained above 85%, leaving a sizable gross-profit base that could support future operating leverage if spending growth moderates.
  • Liquidity strengthened substantially: Cash and short-term investments totaled approximately $121.3 million at Q2 2026, compared with roughly $38.8 million at Q1 2026.
  • Equity position recovered: Total shareholders’ equity increased to $67.7 million from $2.6 million in Q1 2026 and negative equity during much of 2025.
  • Deferred revenue expanded: Current and noncurrent deferred revenue totaled approximately $108.9 million in Q2 2026, up from about $93.3 million a year earlier, providing visibility into future revenue recognition.
  • Operating cash flow was positive in Q2: The $9.2 million inflow was encouraging, but it was supported heavily by working-capital movements and non-cash adjustments rather than net income.
  • Investment activity is volatile: Arteris frequently purchases and sells short-term investments, creating sizable swings in investing cash flow without necessarily indicating changes in core operating performance.
  • Profitability remains distant: The company has reported net losses in every quarterly income statement provided, with a Q2 2026 net loss of $14.1 million and diluted loss of $0.30 per share.
  • Operating losses worsened despite revenue growth: Q2 2026 operating loss increased approximately 50% year over year as research, marketing and administrative spending rose faster than revenue.
  • Shareholder dilution is significant: Weighted-average basic shares increased to 47.3 million in Q2 2026 from 35.3 million in Q2 2023, while the $72.3 million equity issuance in Q2 2026 indicates that financing needs remain an important consideration for investors.

Overall, Arteris is demonstrating improving commercial momentum and now has substantially more cash to fund operations. Nevertheless, the investment case remains dependent on whether revenue growth can eventually produce operating leverage. Until losses narrow and cash generation becomes consistently positive without equity issuance or working-capital benefits, financial risk and dilution remain elevated.

10/14/26 11:42 PM ETAI Generated. May Contain Errors.

Arteris Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Arteris' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Arteris' net income appears to be on a downward trend, with a most recent value of -$34.75 million in 2025, falling from -$3.26 million in 2020. The previous period was -$33.64 million in 2024. View Arteris' forecast to see where analysts expect Arteris to go next.

Arteris' total operating income in 2025 was -$33.14 million, based on the following breakdown:
  • Total Gross Profit: $63.68 million
  • Total Operating Expenses: $96.82 million

Over the last 5 years, Arteris' total revenue changed from $31.81 million in 2020 to $70.58 million in 2025, a change of 121.9%.

In the past 12 quarters, Arteris' cash and equivalents has ranged from $11.67 million in Q1 2026 to $93.27 million in Q2 2026, and is currently $93.27 million as of their latest financial filing in Q2 2026.

Arteris had total debt of $0.00 at the end of 2025, compared with none in 2024, and a 100.0% decrease since 2020.

Over the last 5 years, Arteris' book value per share changed from -0.68 in 2020 to -0.34 in 2025, a change of 51.0%.


Related Companies

Financial statements for NASDAQ:AIP last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
A new income category is drawing serious money - here's why
Forbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...
Investors Alley | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Do this before December or regret it
Porter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...
Porter & Company | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
Federal Reserve Reveals Disturbing New Plan To Control Your Money
A Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...
Weiss Ratings | Sponsoredtc pixel
Trump’s issues shocking Executive Order on U.S. Dollar
Three days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....
Banyan Hill Publishing | Sponsoredtc pixel
I'm giving you a space stock today. Free.
On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...
Behind the Markets | Sponsoredtc pixel
Elon Musk’s One Stock Retirement Plan
Jeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...
Brownstone Research | Sponsoredtc pixel